STAT3 and neoplasm: Immunohistochemistry (IHC) analysis confirmed loss of pY-Stat3 and Stat3 in Ptenpc−/−Stat3pc−/− tumour cells (Supplementary Fig. 2b), while still being present in stromal cells (Supplementary Fig. 2c).